UnitedHealth Group reported strong Q3 results, exceeding expectations and raising full-year guidance, which should positively impact the stock in the short term. While management expressed cautious optimism about 2020 due to factors like the returning health insurance tax and ongoing investments, the overall tone remains positive. The strong performance and raised outlook for 2019 are expected to outweigh concerns and lead to a positive short-term stock impact.

[1]